Business Context and Reporting Period
This Form 8-K filing by Runway Growth Finance Corp. (RWAY) reports a significant corporate event dated May 9, 2024, with the report filed on May 15, 2024. The Company is an emerging growth company incorporated in Maryland, with principal executive offices in Chicago, Illinois. The filing details a secondary offering of common stock by a major stockholder.
Key Financial Metrics
The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt levels, or liquidity ratios. The document focuses exclusively on the terms of a securities offering.
Material Changes and Events
The primary material event is the entry into an Underwriting Agreement on May 9, 2024, for the sale of shares by OCM Growth Holdings, LLC (the "Selling Stockholder"). Key details include:
- Shares Sold: 3,750,000 shares of common stock, par value $0.01 per share.
- Overallotment Option: Underwriters may purchase up to an additional 562,500 shares.
- Underwriters: Wells Fargo Securities, LLC, Morgan Stanley & Co. LLC, BofA Securities, Inc., and UBS Securities LLC.
- Proceeds: The filing does not disclose the offering price per share or the total gross proceeds; these are expected to be detailed in the referenced prospectus supplements.
- Registration: The offering was made pursuant to an effective shelf registration statement on Form N-2 (No. 333-274352).
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors beyond standard legal disclaimers. The document notes that the offering is subject to customary representations, warranties, covenants, and indemnification provisions. It explicitly states that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the final offering price per share and total gross proceeds in the final prospectus supplement dated May 9, 2024.
- Confirm the extent to which the overallotment option (562,500 shares) was exercised by the underwriters.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification terms.
- Assess the impact of this secondary offering on the Company's outstanding share count and potential dilution to existing shareholders.
- Check subsequent filings for any updates on the Selling Stockholder's remaining holdings post-offering.